Health Technology Assessment and Market Access Learnings from the Experience of PD-1 Inhibitors

Event Date: Feb 24, 2016

February 24, 2016

The first webinar in a series on key trends in market access in 2016. Discuss critical issues in market access and HEOR, their implications for manufacturers, and submit questions during webinar.

Event Details Available Here.

You might also be interested in:

PAI and BresMed Join Forces to Support Expanded Use of More… 07/22/2019
Biomarkers and Companion diagnostics: Payer Insights 09/26/2019
ICER Signs Multi-Year Deal to Use New Cloud-Based Analytic… 02/20/2020
Real World Evidence (RWE) Solutions Market by Component,… 02/05/2020
The Future of Personalised Medicine: The Role of Simulation… 01/25/2020
Global Health Economics & Outcomes Research (HEOR) Services… 10/23/2019
Biosimilars: U.S. Market Analysis, Insights and Forecast, 2019-2026 08/19/2019